Candidate drugs against SARS-CoV-2 and COVID-19
Outbreak and pandemic of coronavirus SARS-CoV-2 in 2019/2020 will challenge global health for the future. Because a vaccine against the virus will not be available in the near future, we herein try to offer a pharmacological strategy to combat the virus. There exists a number of candidate drugs that...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12169
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S1043661820311671?via%3Dihub
http://hdl.handle.net/20.500.12010/12169
https://doi.org/10.1016/j.phrs.2020.104859
- Palabra clave:
- COVID-19
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Drugs
Camostat
Chloroquine
Remdesivir
Lopinavir
Ritonavir
Favipiravir
Arbidol
Phytochemicals
- Rights
- License
- Acceso restringido